摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-L-亮氨酸N-羟基琥珀酰亚胺脂 | 3392-09-4

中文名称
Boc-L-亮氨酸N-羟基琥珀酰亚胺脂
中文别名
BOC-L-亮氨酸琥珀酰亚胺酯;N-叔丁氧羰基-L-亮氨酸N-羟基琥珀酰亚胺酯
英文名称
Boc-Leu-ONSu
英文别名
Boc-Leu-OSu;Boc-L-Leu-OSu;(2,5-dioxopyrrolidin-1-yl) (2S)-2-(tert-butoxycarbonylamino)-4-methyl-pentanoate;(2,5-dioxopyrrolidin-1-yl) (2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
Boc-L-亮氨酸N-羟基琥珀酰亚胺脂化学式
CAS
3392-09-4
化学式
C15H24N2O6
mdl
——
分子量
328.365
InChiKey
WXRGJQZMGGGTSS-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    110-113 °C(lit.)
  • 密度:
    1.20±0.1 g/cm3(Predicted)
  • 稳定性/保质期:

    如果按照规定使用和储存,则不会发生分解,目前没有已知危险。

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    23
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    102
  • 氢给体数:
    1
  • 氢受体数:
    6

安全信息

  • WGK Germany:
    3
  • 储存条件:
    -20°C,应密封保存于阴凉干燥处。

SDS

SDS:420b34b3d24b93ac55f5c834c2e50ffc
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Boc-Leu-OSu
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Boc-Leu-OSu
CAS number: 3392-09-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C15H24N2O6
Molecular weight: 328.4

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Antibacterial 5′-O-(N-dipeptidyl)-sulfamoyladenosines
    摘要:
    The aminoacyl-tRNA synthetase (aaRS) class of enzymes is a validated target for antimicrobial development. Aminoacyl analogues of 5'-O-(N-L-aminoacyl)-sulfamoyladenosines are known to be potent inhibitors of aaRS, but whole cell antibacterial activity of these compounds is very limited, and poor penetration into bacteria has been proposed as the main reason for this. Aiming to find derivatives that better penetrate bacteria, we developed a simple and short method to prepare dipeptidyl-derivatives of 5'-O-(N-L-aminoacyl)-sulfamoyladenosines, and used this method to prepare 18 5'-O-(N-dipeptidyl)-sulfamoyladenosines. The antibacterial activity of these derivatives and a number of reference compounds against S. aureus, E. faecalis and E. coli was determined. Several of the new derivatives showed improved antibacterial activity and an altered spectrum of antibacterial activity. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.11.054
  • 作为产物:
    描述:
    N-叔丁氧羰基-L-亮氨醇 在 sodium azide 、 palladium 10% on activated carbon 、 氢气三乙胺 作用下, 以 乙醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 117.0h, 生成 Boc-L-亮氨酸N-羟基琥珀酰亚胺脂
    参考文献:
    名称:
    N-末端硫脲修饰的螺旋 l-Leu 肽与环状氨基酸催化的不对称 1,4-加成反应
    摘要:
    N-末端硫脲修饰的基于l -Leu 的肽 {(3,5-diCF 3 Ph)NHC(=S)-( l -Leu- l -Leu-Ac 5 c) 2 -OMe} 具有五元环α,α-二取代的α-氨基酸(Ac 5 c)催化了β-硝基苯乙烯和丙二酸二甲酯之间的高度对映选择性1,4-加成反应。在i Pr 2 EtN(2.5 当量)存在下,对映选择性反应仅需要 0.5 mol% 的手性肽催化剂,并得到 1,4-加合物,93% ee,产率为 85%。作为迈克尔受体,各种β-硝基苯乙烯衍生物,如甲基、对氟、对溴和对可以应用苯基上的-甲氧基取代基、2-呋喃基、2-噻吩基和萘基β-硝基乙烯。此外,各种丙二酸烷基酯和环状β-酮酯可用作迈克尔供体。很明显,肽链的长度、右手螺旋结构、酰胺 N-Hs 和 N 端硫脲部分在不对称诱导中起着至关重要的作用。
    DOI:
    10.1002/chem.202101252
点击查看最新优质反应信息

文献信息

  • A facile synthesis and crystallographic analysis of N-protected β-amino alcohols and short peptaibols
    作者:Sandip V. Jadhav、Anupam Bandyopadhyay、Sushil N. Benke、Sachitanand M. Mali、Hosahudya N. Gopi
    DOI:10.1039/c0ob01226b
    日期:——
    for the synthesis of N-protected β-amino alcohols and peptaibols using N-hydroxysuccinimide active esters is described. Using this method, dipeptide, tripeptide and pentapeptide alcohols were isolated in high yields. The conformations in crystals of β-amino alcohol, dipeptide and tripeptide alcohols were analysed, with a well-defined type III β-turn being observed in the tripeptide alcohol crystals
    一种简便,高效且无外消旋的方法,使用该方法合成N保护的β-基醇和肽醇N-羟基琥珀酰亚胺描述了活性酯。使用这种方法,可以高产率分离出二肽,三肽和五肽醇。分析了β-基醇,二肽和三肽醇的晶体构象,在三肽醇晶体中观察到了明确定义的III型β角。发现该方法与Fmoc-,Boc-和其他侧链保护基相容。
  • Synthesis of a Partial Sequence of Proinsulin Using the A-Chain of Natural Insulin. II. Synthesis of a Peptide Corresponding to Positions 53–81 of Bovine Proinsulin
    作者:Hiroko Aiba、Yasutsugu Shimonishi
    DOI:10.1246/bcsj.53.192
    日期:1980.1
    For the synthesis of bovine proinsulin, the S-sulfonate of the Leu–Glu–Gly–Pro–Pro–Gln–Lys[Z(2-Cl)]–Arg–A-chain, which was synthesized using the S-sulfonate of the A-chain of natural bovine insulin and which corresponds to positions 53–81 of bovine proinsulin, was coupled with Boc–Ala–Leu–Glu(OBut)–Leu–Ala–Gly–Gly–Pro–Gly–Ala–Gly–Gly–N3. After removal of the protecting groups from the resulting material
    对于牛胰岛素原的合成,Leu-Glu-Gly-Pro-Pro-Gln-Lys[Z(2-Cl)]-Arg-A-链的 S-磺酸盐,它是使用 S-磺酸盐合成的天然牛胰岛素的 A 链对应于牛胰岛素原的 53-81 位,与 Boc-Ala-Leu-Glu(OBut)-Leu-Ala-Gly-Gly-Pro-Gly-Ala-Gly-偶联Gly-N3。从所得材料中去除保护基团后,Ala–Leu–Glu–Leu–Ala–Gly–Gly–Pro–Gly–Ala–Gly–Gly–Leu–Glu–Gly–Pro–Pro– 的 S-磺酸盐Gln-Lys[Z(2-Cl)]-Arg-A-链,对应于牛胰岛素原的 41-81 位,通过 QAE-Sephadex A-25 色谱纯化。
  • [EN] MACROCYCLIZATION OF PEPTIDOMIMETICS<br/>[FR] MACROCYCLISATION DE PEPTIDOMIMÉTIQUES
    申请人:UNIV WARWICK
    公开号:WO2019186174A1
    公开(公告)日:2019-10-03
    The invention provides an improved method of macrocyclization of peptidomimetics, as measured by isolated yields and product distribution, which comprises substitution of one or more of the backbone amide C=O bonds with a turn-inducing motif. The method is general with enhancements seen across a range of ring sizes (e.g. tri-, tetra-, penta- and hexapeptides). Specifically, the invention provides a peptidomimetic macrocycle comprising a carbonyl bioisosteric turn-inducing element having the structure: (I) wherein X is a heteroatom; and wherein R1 to R6 are each independently selected from alkyl, aryl, heteroaryl and H.
    该发明提供了一种改进的肽类类似物的大环化方法,通过孤立产量和产物分布来衡量,其中包括用诱导转向基团替代一个或多个骨架酰胺C=O键。该方法是通用的,在一系列环大小(例如三肽、四肽、五肽和六肽)中均可见到增强效果。具体而言,该发明提供了一种包含具有结构的羰基生物等同体诱导转向元素的肽类类似物大环:(I)其中X是杂原子;其中R1至R6分别独立地选自烷基、芳基、杂芳基和氢。
  • Binding and Action of Amino Acid Analogs of Chloramphenicol upon the Bacterial Ribosome
    作者:Andrey G. Tereshchenkov、Malgorzata Dobosz-Bartoszek、Ilya A. Osterman、James Marks、Vasilina A. Sergeeva、Pavel Kasatsky、Ekaterina S. Komarova、Andrey N. Stavrianidi、Igor A. Rodin、Andrey L. Konevega、Petr V. Sergiev、Natalia V. Sumbatyan、Alexander S. Mankin、Alexey A. Bogdanov、Yury S. Polikanov
    DOI:10.1016/j.jmb.2018.01.016
    日期:2018.3
    bacterial ribosome and inhibits peptide bond formation. As an approach for modifying and potentially improving properties of this inhibitor, we explored ribosome binding and inhibitory activity of a number of amino acid analogs of CHL. The L-histidyl analog binds to the ribosome with the affinity exceeding that of CHL by 10 fold. Several of the newly synthesized analogs were able to inhibit protein synthesis
    抗生素氯霉素(CHL)以中等亲和力结合在细菌核糖体的肽基转移酶中心,并抑制肽键的形成。作为修饰和潜在改善该抑制剂性质的方法,我们探索了核糖体结合和许多CHL氨基酸类似物的抑制活性。L-组氨酸类似物以超过CHL十倍的亲和力与核糖体结合。一些新合成的类似物能够抑制蛋白质合成,并表现出不同于CHL的作用方式。然而,半合成CHL类似物的抑制特性与其亲和力不相关,并且一般而言,与原始抗生素相比,CHL的氨基酸类似物是不太有效的翻译抑制剂。与三个半合成类似物复合的嗜热栖热菌70S核糖体显示,CHL衍生物在肽基转移酶中心结合,在那里被测化合物的酰基部分与rRNA建立了特异相互作用。尽管仍然是效率低下的翻译抑制剂,但合成的化合物仍代表着有前途的化学支架,其靶向核糖体的肽基转移酶中心,并可能适合进一步研究。
  • Synthesis of the Five Peptide Derivatives Needed to Build the Sequence Corresponding to 1–30 of Human Epidermal Growth Factor (h-EGF)
    作者:Song Yuh Shin、Yukihiko Kaburaki、Masanori Watanabe、Eisuke Munekata
    DOI:10.1271/bbb.56.399
    日期:1992.1
    For the classical solution synthesis of human epidermal growth factor (h-EGF), five protected peptide derivatives, Boc-Leu-Asp(OcHex)-Lys(Cl-Z)-Tyr(Br-Z)-Ala-OH (5), Boc-Val-Cys(MeBzl)-Met-Tyr(Br-Z)-Ile-Glu(OcHex)-Ala-OH (12), Boc-Tyr(Br-Z)-Cys(MeBzl)-Leu-His-Asp(OcHex)-Gly-OH (18), Boc-Cys(MeBzl)-Pro-Leu-Ser(Bzl)-His-Asp(OcHex)-Gly-O H (23) and Boc-Asn-Ser(Bzl)-Asp(OcHex)-Ser(Bzl)-Glu(OcHex)-OH (28) were synthesized to build up the sequence corresponding to 1–30.
    对于人表皮生长因子(h-EGF)的经典合成解决方案,合成了五种保护性肽衍生物,即Boc-Leu-Asp(OcHex)-Lys(Cl-Z)-Tyr(Br-Z)-Ala-OH(5),Boc-Val-Cys(MeBzl)-Met-Tyr(Br-Z)-Ile-Glu(OcHex)-Ala-OH(12),Boc-Tyr(Br-Z)-Cys(MeBzl)-Leu-His-Asp(OcHex)-Gly-OH(18),Boc-Cys(MeBzl)-Pro-Leu-Ser(Bzl)-His-Asp(OcHex)-Gly-O H(23)和Boc-Asn-Ser(Bzl)-Asp(OcHex)-Ser(Bzl)-Glu(OcHex)-OH(28),以构建对应于1-30的序列。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸